{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:37:11Z","timestamp":1788885431912,"version":"build-2803163510"},"reference-count":53,"publisher":"Bentham Science Publishers Ltd.","issue":"7","funder":[{"DOI":"10.13039\/501100001321","name":"South African National Research Foundation","doi-asserted-by":"publisher","award":["PMDS22062928944"],"award-info":[{"award-number":["PMDS22062928944"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"South African National Research Foundation","doi-asserted-by":"publisher","award":["TTK210219587225"],"award-info":[{"award-number":["TTK210219587225"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>According to the World Health Organisation, cardiovascular complications\nhave been recognized as the leading course of death between 2000 and 2019.\nCardiovascular complications are caused by excess LDL cholesterol in the body or arteries that can\nbuild up to form a plaque. There are drugs currently in clinical use called statins that target HMGCoA\nreductase. However, these drugs result in several side effects. This work investigated using\ncomputational approaches to lower cholesterol by investigating green tea extracts as an inhibitors\nfor squalene monooxygenase (the second-rate-controlling step in cholesterol synthesis).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>Pharmacophore modeling was done to identify possible pharmacophoric sites based on\nthe pIC50 values. The best hypothesis generated by pharmacophore modeling was further validated\nby atom-based 3D QSAR, where 70% of the data set was treated as the training set. Prior molecular\ndocking ADMET studies were done to investigate the physiochemical properties of these\nmolecules. Glide docking was performed, followed by molecular dynamics to evaluate the protein\nconformational changes.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Pharmacophore results suggest that the best molecules to interact with the biological target\nshould have at least one hydrogen acceptor (A5), two hydrogen donors (D9 and D10), and two\nbenzene rings (R14 and R15) for green tea polyphenols and theasinensin A. ADMET result shows\nthat all molecules in this class have low oral adsorption. Molecular docking results showed that\nsome green tea polyphenols have good binding affinities, with most of these structures having a\ndocking score of less than -10 kcal\/mol. Molecular dynamics further illustrated that the best-docked\nligands perfectly stay within the active site over a 100 ns simulation.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The results obtained from this study suggest that green tea polyphenols have the\npotential for inhibition of squalene monooxygenase, except for theasinensin A.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115734064280290240211170037","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T08:54:00Z","timestamp":1712307240000},"page":"721-732","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A Computational Study of Green Tea Extracts and their Derivatives as\nPotential Inhibitors for Squalene Monooxygenase"],"prefix":"10.2174","volume":"20","author":[{"given":"Kabelo Phuti","family":"Mokgopa","sequence":"first","affiliation":[{"name":"Department of Chemistry, Rhodes University, Makhanda, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Lobb","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Rhodes University, Makhanda, South Africa"},{"name":"Research Unit in Bioinformatics (RUBi),\nRhodes University, Makhanda, 6140, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tendamudzimu","family":"Tshiwawa","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Rhodes University, Makhanda, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1111\/j.1558-5646.2010.01011.x","volume":"64","author":"Brown A.J.","year":"2010","unstructured":"Brown A.J.; Galea A.M.; Cholesterol as an evolutionary response to living with oxygen. Evolution  2010,64(7),2179-2183","journal-title":"Evolution"},{"key":"ref=2","author":"Craig M.","year":"2022","unstructured":"Craig M.; Yarrarapu S.N.S.; Dimri M.;  Biochemistry, Cholesterol  2022","journal-title":"Biochemistry, Cholesterol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"101033","DOI":"10.1016\/j.plipres.2020.101033","volume":"79","author":"Chua N.K.","year":"2020","unstructured":"Chua N.K.; Coates H.W.; Brown A.J.; Squalene monooxygenase: A journey to the heart of cholesterol synthesis. Prog Lipid Res  2020,79,101033","journal-title":"Prog Lipid Res"},{"key":"ref=4","author":"Alberts B.","year":"2002","unstructured":"Alberts B.; Johnson A.; Lewis J.; Raff M.; Roberts K.; Walter P.; The lipid bilayer. In Mol Biol Cell  \n https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK26871\/\n2002","journal-title":"In Mol Biol Cell"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1749-6632.2002.tb04839.x","volume":"977","author":"Burns M.","year":"2002","unstructured":"Burns M.; Duff K.; Cholesterol in alzheimer\u2019s disease and tauopathy. Ann N Y Acad Sci  2002,977(1),367-375","journal-title":"Ann N Y Acad Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/9780470720745.ch5","author":"Goldstein J.L.","year":"1982","unstructured":"Goldstein J.L.; Anderson R.G.; Brown M.S.; Receptor-mediated endocytosis and the cellular uptake of low density lipoprotein. Ciba Found Symp  1982(92),77-95","journal-title":"Ciba Found Symp"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1006\/abbi.2001.2615","volume":"397","author":"Goldstein J.L.","year":"2002","unstructured":"Goldstein J.L.; Rawson R.B.; Brown M.S.; Mutant mammalian cells as tools to delineate the sterol regulatory element-binding protein pathway for feedback regulation of lipid synthesis. Arch Biochem Biophys  2002,397(2),139-148","journal-title":"Arch Biochem Biophys"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.21037\/atm.2016.06.33","volume":"4","author":"Sanchis-Gomar F.","year":"2016","unstructured":"Sanchis-Gomar F.; Perez-Quilis C.; Leischik R.; Lucia A.; Epidemiology of coronary heart disease and acute coronary syndrome. Ann Transl Med  2016,4(13),256","journal-title":"Ann Transl Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1136\/bmj.311.6998.171","volume":"311","author":"Barker D.J.P.","year":"1995","unstructured":"Barker D.J.P.; Fetal origins of coronary heart disease. BMJ  1995,311(6998),171-174","journal-title":"BMJ"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2796.2012.02553.x","volume":"272","author":"Willett W.C.","year":"2012","unstructured":"Willett W.C.; Dietary fats and coronary heart disease. J Intern Med  2012,272(1),13-24","journal-title":"J Intern Med"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1093\/rheumatology\/kei142","volume":"44","author":"Bruce I.N.","year":"2005","unstructured":"Bruce I.N.; Not only\u2026 but also\u2019: factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology  2005,44(12),1492-1502","journal-title":"Rheumatology"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1007\/s10880-008-9117-8","volume":"15","author":"Skodova Z.","year":"2008","unstructured":"Skodova Z.; Nagyova I.; van Dijk J.P.; Sudzinova A.; Vargova H.; Studencan M.; Reijneveld S.A.; Socioeconomic differences in psychosocial factors contributing to coronary heart disease: A review. J Clin Psychol Med Settings  2008,15(3),204-213","journal-title":"J Clin Psychol Med Settings"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S1388-1981(00)00153-0","volume":"1529","author":"Jonas A.","year":"2000","unstructured":"Jonas A.; Lecithin cholesterol acyltransferase. Biochim Biophys Acta Mol Cell Biol Lipids  2000,1529(1-3),245-256","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1161\/01.ATV.17.9.1813","volume":"17","author":"Remaley A.T.","year":"1997","unstructured":"Remaley A.T.; Schumacher U.K.; Stonik J.A.; Farsi B.D.; Nazih H.; Brewer H.B.; Decreased reverse cholesterol transport from tangier disease fibroblasts: Acceptor specificity and effect of brefeldin on lipid efflux. Arterioscler Thromb Vasc Biol  1997,17(9),1813-1821","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/S1388-1981(00)00152-9","volume":"1529","author":"Yokoyama S.","year":"2000","unstructured":"Yokoyama S.; Release of cellular cholesterol: Molecular mechanism for cholesterol homeostasis in cells and in the body. Biochim Biophys Acta Mol Cell Biol Lipids  2000,1529(1-3),231-244","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"ref=16","first-page":"219","volume":"14","author":"Gramza A.","year":"2005","unstructured":"Gramza A.; Korczak J.; Amarowicz R.; Tea polyphenols-their antioxidant properties and biological activity-a review. Pol J Food Nutr Sci  2005,14,219","journal-title":"Pol J Food Nutr Sci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/S0378-8741(02)00217-9","volume":"83","author":"Sabu M.C.","year":"2002","unstructured":"Sabu M.C.; Smitha K.; Kuttan R.; Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J Ethnopharmacol  2002,83,109-116","journal-title":"J Ethnopharmacol"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/187152907780830905","volume":"7","author":"Tipoe G. L.","year":"2007","unstructured":"Tipoe G. L.; Leung T.; Hung M.; Fung M.; Green tea polyphenols as an anti-oxidant and anti-inflammatory agent for cardiovascular protection. Cardiovascular and Haematological Disorders- Drug Targets (Formerly Current Drug Targets-Cardiovascular and Hematological Disorders)  2007,7,135-144","journal-title":"Cardiovascular and Haematological Disorders- Drug Targets (Formerly Current Drug Targets-Cardiovascular and Hematological Disorders)"},{"key":"ref=19","first-page":"85","author":"Alexopoulos N.","year":"2010","unstructured":"Alexopoulos N.; Vlachopoulos C.; Stefanadis C.; Role of green tea in reduction of cardiovascular risk factors. Nutr Diet Suppl  2010,85-95","journal-title":"Nutr Diet Suppl"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1006\/bbrc.2000.2217","volume":"268","author":"Abe I.","year":"2000","unstructured":"Abe I.; Seki T.; Umehara K.; Miyase T.; Noguchi H.; Sakakibara J.; Ono T.; Green tea polyphenols: Novel and potent inhibitors of squalene epoxidase. Biochem Biophys Res Commun  2000,268(3),767-771","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=21","year":"2014","unstructured":"MarvinSketch 22.11, 2014, ChemAxon  Available from:\n http:\/\/www.chemaxon.com2014"},{"key":"ref=22","author":"Release S.","year":"2023","unstructured":"Release S.;  2023-2: Maestro  2023","journal-title":"2023-2: Maestro"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","volume":"20","author":"Dixon S.L.","year":"2006","unstructured":"Dixon S.L.; Smondyrev A.M.; Knoll E.H.; Rao S.N.; Shaw D.E.; Friesner R.A.; PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J Comput Aided Mol Des  2006,20(10-11),647-671","journal-title":"J Comput Aided Mol Des"},{"key":"ref=24","year":"2021","unstructured":"QikProp  2021","journal-title":"QikProp"},{"key":"ref=25","author":"Release S.","year":"2023","unstructured":"Release S.;  2023-2: LigPrep  2023","journal-title":"2023-2: LigPrep"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"58","author":"Pires D.","year":"2015","unstructured":"Pires D.; Blundell T.L.; pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem  2015,58(9),4066-4072","journal-title":"J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"42717","DOI":"10.1038\/srep42717","volume":"7","author":"Daina A.","year":"2017","unstructured":"Daina A.; Michielin O.; Zoete V.; SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep  2017,7(1),42717","journal-title":"Sci Rep"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/ct900587b","volume":"6","author":"Shivakumar D.","year":"2010","unstructured":"Shivakumar D.; Williams J.; Wu Y.; Damm W.; Shelley J.; Sherman W.; Prediction of absolute solvation free energies using molecular dynamics free energy perturbation and the OPLS force field. J Chem Theory Comput  2010,6(5),1509-1519","journal-title":"J Chem Theory Comput"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s10822-010-9349-1","volume":"24","author":"Greenwood J.R.","year":"2010","unstructured":"Greenwood J.R.; Calkins D.; Sullivan A.P.; Shelley J.C.; Towards the comprehensive, rapid, and accurate prediction of the favorable tautomeric states of drug-like molecules in aqueous solution. J Comput Aided Mol Des  2010,24(6-7),591-604","journal-title":"J Comput Aided Mol Des"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"Madhavi S.G.","year":"2013","unstructured":"Madhavi S.G.; Adzhigirey M.; Day T.; Annabhimoju R.; Sherman W.; Protein and ligand preparation: Parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des  2013,27(3),221-234","journal-title":"J Comput Aided Mol Des"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"Friesner R.A.","year":"2006","unstructured":"Friesner R.A.; Murphy R.B.; Repasky M.P.; Frye L.L.; Greenwood J.R.; Halgren T.A.; Sanschagrin P.C.; Mainz D.T.; Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein\u2212ligand complexes. J Med Chem  2006,49(21),6177-6196","journal-title":"J Med Chem"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1109\/SC.2006.54","author":"Bowers K.J.","year":"2006","unstructured":"Bowers K.J.; Chow E.; Xu H.; Dror R.O.; Eastwood M.P.; Gregersen B.A.; Klepeis J.L.; Kolossvary I.; Moraes M.A.; Sacerdoti F.D.; Salmon J.K.; Shan Y.; Shaw D.E.;  Proceedings of the ACM\/IEEE Conference on Supercomputing (SC06)  November 11-172006","journal-title":"Proceedings of the ACM\/IEEE Conference on Supercomputing (SC06)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1021\/jp506555w","volume":"119","author":"Jiang L.","year":"2015","unstructured":"Jiang L.; Rizzo R.C.; Pharmacophore-based similarity scoring for dock. J Phys Chem B  2015,119(3),1083-1102","journal-title":"J Phys Chem B"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S0304-4076(96)01818-0","volume":"77","author":"Colin C.A.","year":"1997","unstructured":"Colin C.A.; Windmeijer F.A.G.; An R-squared measure of goodness of fit for some common nonlinear regression models. J Econom  1997,77(2),329-342","journal-title":"J Econom"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1213\/ANE.0000000000002864","volume":"126","author":"Schober P.","year":"2018","unstructured":"Schober P.; Boer C.; Schwarte L.A.; Correlation coefficients: Appropriate use and interpretation. Anesth Analg  2018,126(5),1763-1768","journal-title":"Anesth Analg"},{"key":"ref=36","first-page":"206","author":"Chin W.W.","year":"1998","unstructured":"Chin W.W.; Henseler J.; Wang H.;  Handbook of partial least squares: Concepts, methods and applications  1998,206","journal-title":"Handbook of partial least squares: Concepts, methods and applications"},{"key":"ref=37","first-page":"511","volume":"2","author":"Veerasamy R.","year":"2011","unstructured":"Veerasamy R.; Rajak H.; Jain A.; Sivadasan S.; Varghese C.P.; Agrawal R.K.; Validation of QSAR models - strategies and importance. Int J Drug Des Disocovery  2011,2(3),511-519","journal-title":"Int J Drug Des Disocovery"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"113","DOI":"10.4103\/2229-3485.100662","volume":"3","author":"Barde P.","year":"2012","unstructured":"Barde P.; Barde M.; What to use to express the variability of data: Standard deviation or standard error of mean? Perspect Clin Res  2012,3(3),113","journal-title":"Perspect Clin Res"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.5194\/gmd-7-1247-2014","volume":"7","author":"Chai T.","year":"2014","unstructured":"Chai T.; Draxler R.R.; Root mean square error (RMSE) or mean absolute error (MAE)? \u2013 Arguments against avoiding RMSE in the literature. Geosci Model Dev  2014,7(3),1247-1250","journal-title":"Geosci Model Dev"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","volume":"9","author":"Bos J.D.","year":"2000","unstructured":"Bos J.D.; Meinardi M.M.H.M.; The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol  2000,9(3),165-169","journal-title":"Exp Dermatol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1001\/archinte.163.8.949","volume":"163","author":"Ensrud K.E.","year":"2003","unstructured":"Ensrud K.E.; Blackwell T.; Mangione C.M.; Bowman P.J.; Bauer D.C.; Schwartz A.; Hanlon J.T.; Nevitt M.C.; Whooley M.A.; Central nervous system active medications and risk for fractures in older women. Arch Intern Med  2003,163(8),949-957","journal-title":"Arch Intern Med"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/rmv.454","volume":"15","author":"Strazielle N.","year":"2005","unstructured":"Strazielle N.; Ghersi-Egea J.F.; Factors affecting delivery of antiviral drugs to the brain. Rev Med Virol  2005,15(2),105-133","journal-title":"Rev Med Virol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/jps.20378","volume":"94","author":"Li S.","year":"2005","unstructured":"Li S.; He H.; Parthiban L.J.; Yin H.; Serajuddin A.T.M.; IV-IVC considerations in the development of immediate-release oral dosage form. J Pharm Sci  2005,94(7),1396-1417","journal-title":"J Pharm Sci"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.addr.2016.05.007","volume":"101","author":"Benet L.Z.","year":"2016","unstructured":"Benet L.Z.; Hosey C.M.; Ursu O.; Oprea T.I.; BDDCS, the Rule of 5 and drugability. Adv Drug Deliv Rev  2016,101,89-98","journal-title":"Adv Drug Deliv Rev"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"112290","DOI":"10.1016\/j.ejmech.2020.112290","volume":"195","author":"Garrido A.","year":"2020","unstructured":"Garrido A.; Lepailleur A.; Mignani S.M.; Dallemagne P.; Rochais C.; hERG toxicity assessment: Useful guidelines for drug design. Eur J Med Chem  2020,195,112290","journal-title":"Eur J Med Chem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1002\/jps.21010","volume":"97","author":"Volpe D.A.","year":"2008","unstructured":"Volpe D.A.; Variability in caco-2 and MDCK cell-based intestinal permeability assays. J Pharm Sci  2008,97(2),712-725","journal-title":"J Pharm Sci"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","volume":"7","author":"Daneman R.","year":"2015","unstructured":"Daneman R.; Prat A.; The blood\u2013brain barrier. Cold Spring Harb Perspect Biol  2015,7(1),a020412","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.bmcl.2003.11.072","volume":"14","author":"Sawada M.","year":"2004","unstructured":"Sawada M.; Washizuka K.; Okumura H.; Synthesis and biological activity of a novel squalene epoxidase inhibitor, FR194738. Bioorg Med Chem Lett  2004,14(3),633-637","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/BF00054556","volume":"6","author":"Russell D.W.","year":"1992","unstructured":"Russell D.W.; Cholesterol biosynthesis and metabolism. Cardiovasc Drugs Ther  1992,6(2),103-110","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1055\/s-2003-45142","volume":"69","author":"Hatano T.","year":"2003","unstructured":"Hatano T.; Kusuda M.; Hori M.; Shiota S.; Tsuchiya T.; Yoshida T.; Theasinensin A, a tea polyphenol formed from (-)-epigallocatechin gallate, suppresses antibiotic resistance of methicillin-resistant Staphylococcus aureus. Planta Med  2003,69(11),984-989","journal-title":"Planta Med"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1021\/ci400040d","volume":"53","author":"Elokely K.M.","year":"2013","unstructured":"Elokely K.M.; Doerksen R.J.; Docking challenge: Protein sampling and molecular docking performance. J Chem Inf Model  2013,53(8),1934-1945","journal-title":"J Chem Inf Model"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"9348","DOI":"10.1021\/acsomega.8b01339","volume":"3","author":"Cabaleiro-Lago E.M.","year":"2018","unstructured":"Cabaleiro-Lago E.M.; Avda Alfonso El Sabio L.X.; On the Nature of \u03c3-\u03c3, \u03c3-\u03c0, and \u03c0-\u03c0 stacking in extended systems. ACS Omega  2018,3(8),9348-9359","journal-title":"ACS Omega"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1002\/prot.20897","volume":"63","author":"Nayal M.","year":"2006","unstructured":"Nayal M.; Honig B.; On the nature of cavities on protein surfaces: Application to the identification of drug\u2010binding sites. Proteins  2006,63(4),892-906","journal-title":"Proteins"}],"container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064280290240211170037","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/228638\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115734064280290240211170037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T06:24:55Z","timestamp":1726813495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/228638\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115734064280290240211170037","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-10-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-09","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-10","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}